Structural Connectomes In Traumatic Brain Injury: Can Secondary Disease Progression Be Stopped And Cognitive Deficits Be Reversed?
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Many people with traumatic brain injury (TBI) experience cognitive problems, including poor memory and concentration. TBI is often referred to as a ‘hidden disability’ because the overwhelming majority of patients with TBI show no abnormalities on standard MRI or CT scans. In my project, I will delineate the mechanisms of secondary injury in finer detail through enhanced neuroimaging techniques, resulting in new assessment and treatment modalities for individuals with TBI.
Mood and anxiety disorders represent a tremendous cause of disability and morbidity. This research will use cutting-edge brain imaging technologies to understand why these disorders typically emerge in young people and whether brain imaging can reliably predict the effectiveness of different treatments for individual patients.
Early Identification Of Degenerative Dementia Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
With the continuing ageing of the population, an increasing number of adults will experience signs of dementia. Knowledge of the clinical presentation, disease mechanisms and evolution of frontotemporal dementia, a syndrome as common as Alzheimer’s disease in the < 65 year-old group, remains suboptimal. This research project will combine clinical investigations and brain imaging to improve diagnostic accuracy of this disease. This will lead to better treatment and management interventions.
Reducing Perinatal Lung, Heart And Brain Injury In Preterm Infants – From Bench To The Clinic.
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
Many infants are exposed to an adverse environment whilst developing in the womb, and are therefore at increased risk of lung, heart and brain injury, with life-long consequences. This research is focused on improving the entry into the world of vulnerable infants, thus reducing the risk and severity of brain injury.
Optimizing Stroke Therapy - Advanced Brain Imaging And Reperfusion Therapies
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Most stroke is due to a blocked blood vessel reducing blood flow to the brain. This research aims to optimize fast restoration of blood flow to the brain and improve patient outcomes. We will test potentially more effective clot-dissolving medication, examine potential benefits of redesigning pre-hospital ambulance transport systems and clarify the role of advanced brain imaging to maximize delivery of recently proven minimally invasive procedures to physically remove blood clots in the brain.
Genetic Influence On Cognitive Function And Medication Response In Attention Deficit Hyperactivity Disorder (ADHD).
Funder
National Health and Medical Research Council
Funding Amount
$401,361.00
Summary
ADHD is one of the most common child mental health conditions, with cognitive deficits that impact everyday functioning, educational and social outcomes. Not all children with ADHD achieve equal benefit from medication. The disorder appears to be genetic with many genes contributing a small risk for the disorder. This project asks how DNA variation influences ADHD brain function and how they respond to medication. This project is important to improve the clinical diagnosis and outcome for ADHD.
Psychiatric research to date has predominantly focused on understanding mental illness and ways to treat it. This research program instead aims to understand the characteristics of those people who are 'resilient' and able to bounce back from trauma and adversity and thrive. For the first time, it will establish the biological brain markers that define resilience, and the impact of genetics and environment in these pathways. This study will also validate personalised solutions to e-health cognit ....Psychiatric research to date has predominantly focused on understanding mental illness and ways to treat it. This research program instead aims to understand the characteristics of those people who are 'resilient' and able to bounce back from trauma and adversity and thrive. For the first time, it will establish the biological brain markers that define resilience, and the impact of genetics and environment in these pathways. This study will also validate personalised solutions to e-health cognitive training tools that aim to boost resilience.Read moreRead less
A Multi-national Trial To Predict Treatment Response In Subtypes Of Depression
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Treatment of MDD using trial and error can have serious consequences. It can prolong the patient’s suffering (depression is associated with substantial morbidity, and mortality), prolong their absence from work and other productive activity and increase the burden on their family-carers. This multi-national study will collect genetics, brain function and behavioural data from a large number of participants, allowing for sensitive predictors of response to be determined.
A Program Of Methodological And Collaborative Research In Biostatistics And Population Health
Funder
National Health and Medical Research Council
Funding Amount
$264,081.00
Summary
Biostatistics is a critical component of health and medical research, especially for studies in population health. However, there is an increasing gap between supply and demand for high-level biostatistical input. This proposal combines novel methodological research into methods for analysing incomplete data, with collaborative research applying new ideas and complex analyses to important health problems. The fellowship will facilitate my development as a future leader in this key area.
Improving Diagnosis Of Early Frontotemporal Dementia Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
Frontotemporal dementia is difficult to identify and diagnose accurately, although it is almost as common as Alzheimer’s disease before the age of 65. Improving its detection and diagnostic accuracy is the focus of my fellowship for the next 4 years. As a neuropsychologist with over 15 years clinical experience in dementia, I will combine clinical, neuroimaging and neuropathological approaches to identify early presentations of frontotemporal dementia and other dementia syndromes.